Actively Recruiting
Recompensation in Alcohol Related Hepatitis
Led by Nina Kimer · Updated on 2025-02-27
160
Participants Needed
1
Research Sites
266 weeks
Total Duration
On this page
Sponsors
N
Nina Kimer
Lead Sponsor
C
Copenhagen University Hospital, Hvidovre
Collaborating Sponsor
AI-Summary
What this Trial Is About
Genetic activity and metabolic changes may be part of the pathogenesis in alcohol related hepatitis. We do not know exactly how alcohol cessation affects liver functions and metabolism. The aim of this study is to assess the impact of alcohol cessation in patients with alcohol related hepatitis and gain knowledge of the metabolic and genetic functions of the liver during remission and recompensation from alcohol related hepatitis. The study will assess 1. The effect of alcohol cessation on the liver. 2. The biological mechanisms involved in healing after alvohol-cessation 3. The effect of motivational enhcament therapy in alcohol cessation after alcohol related hepatitis. 4. The metabolic changes of lipids and proteins in the liver Participants are offered motivational enhancement therapy and standard of care.
CONDITIONS
Official Title
Recompensation in Alcohol Related Hepatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Clinical suspicion of Alcoholic Hepatitis supported by biochemistry (bilirubin 50 mmol/l or higher) and ultrasound or other imaging techniques
- Provided informed written consent
You will not qualify if you...
- Diagnosis of Alcoholic Hepatitis is questionable with reasonable doubt
- Withdrawal of informed consent
- Delayed or not initiated investigational program within two months after diagnosis of suspected Alcoholic Hepatitis
- Presence of hepatocellular carcinoma (liver cancer)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Hvidovre
Hvidovre, Denmark, 2650
Actively Recruiting
Research Team
N
Nina Kimer, MD, PhD
CONTACT
N
Niels P Klausen, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here